Debbie Merrithew [mailto:]
Transcription
Debbie Merrithew [mailto:]
From: Debbie Merrithew [mailto:[email protected]] Sent: November 4, 2015 7:03 AM To: Debbie Merrithew <[email protected]> Subject: Notice: Health Canada Requirements for Manufacturers Relating to Manufacturing Change to Tyvek® 1073B and 1059B Avis: Exigences de Santé Canada à l'égard des fabricants liées à la modification de la fabrication de Tyvek® 1073B et 1059B Notice: Health Canada Requirements for Manufacturers Relating to Manufacturing Change to Tyvek® 1073B and 1059B http://www.hc-sc.gc.ca/dhp-mps/md-im/activit/announce-annonce/tyvek_notice_avis-eng.php Avis: Exigences de Santé Canada à l'égard des fabricants liées à la modification de la fabrication de Tyvek® 1073B et 1059B http://www.hc-sc.gc.ca/dhp-mps/md-im/activit/announce-annonce/tyvek_notice_avis-fra.php From: Valerie Delorme [mailto:[email protected]] Sent: November 6, 2015 11:25 AM To: Valerie Delorme <[email protected]> Subject: Notice: Updates to the Guidance Document: Fees for the Review of Drug Submissions and Applications Avis : Mises a jour a la Ligne directrice - Frais pour l'examen des presentations et de demandes de drogue http://www.hc-sc.gc.ca/dhp-mps/prodpharma/activit/announce-annonce/notice_fee_frais_guide_aviseng.php http://www.hc-sc.gc.ca/dhp-mps/prodpharma/activit/announce-annonce/notice_fee_frais_guide_avisfra.php From: Debbie Merrithew [mailto:[email protected]] Sent: November 16, 2015 1:10 PM To: Debbie Merrithew <[email protected]> Subject: Health Canada: Notice: Antimicrobials Product Labelling Santé Canada: Avis : L'étiquetage des produit pour antimicrobiens November 16, 2015 Health Canada: Notice: Antimicrobials Product Labelling http://www.hc-sc.gc.ca/dhp-mps/prodpharma/activit/announce-annonce/notice-amr-avis-ram-eng.php Le 16 novembre 2015 Santé Canada: Avis : L'étiquetage des produit pour antimicrobiens http://www.hc-sc.gc.ca/dhp-mps/prodpharma/activit/announce-annonce/notice-amr-avis-ram-fra.php From: Valerie Delorme [mailto:[email protected]] Sent: November 23, 2015 6:26 AM To: Valerie Delorme <[email protected]> Subject: Update: Implementation of Plain Language Revisions to Part III: Patient Medication Information and Associated Templates of the Guidance Document: Product Monograph Mise a jour : Mise en ouvre des revisions en langage clair de la partie III des Renseigneme http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/monograph/notice_pmi_aviseng.php http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/monograph/notice_pmi_avisfra.php From: Debbie Merrithew [mailto:[email protected]] Sent: November 25, 2015 1:49 PM To: Debbie Merrithew <[email protected]> Subject: Consultation : Release of Draft (Step 2) International Council on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance: E6 Integrated Addendum: Good Clinical Practice Consultation : Publication de l' The above referenced draft guidance was released by the ICH Steering Committee for consultation and is being posted on the Health Canada website for information and comment in accordance with Step 2 of the ICH process. This consultation is open for comment starting November 25, 2015 until February 1, 2016. http://www.hc-sc.gc.ca/dhp-mps/consultation/drug-medic/consult-e6-add-step2etape-eng.php La ligne directrice susmentionnée a été publiée par le comité directeur de l'ICH à des fins de consultation et est publiée sur le site Web de Santé Canada à titre d'information et en vue de recueillir des commentaires conformément à l'étape 2 du processus de l'ICH. Cette consultation est disponible pour vos commentaires du 25 novembre 2015 au 1 février 2016. http://www.hc-sc.gc.ca/dhp-mps/consultation/drug-medic/consult-e6-add-step2etape-fra.php